Unknown

Dataset Information

0

Optical scattering as an early marker of apoptosis during chemotherapy and antiangiogenic therapy in murine models of prostate and breast cancer.


ABSTRACT: Monitoring of the in vivo tumor state to track therapeutic response in real time may help to evaluate new drug candidates, maximize treatment efficacy, and reduce the burden of overtreatment. Current preclinical tumor imaging methods have largely focused on anatomic imaging (e.g., MRI, ultrasound), functional imaging (e.g., FDG-PET), and molecular imaging with exogenous contrast agents (e.g., fluorescence optical tomography). Here we utalize spatial frequency domain imaging (SFDI), a noninvasive, label-free optical technique, for the wide-field quantification of changes in tissue optical scattering in preclinical tumor models during treatment with chemotherapy and antiangiogenic agents. Optical scattering is particularly sensitive to tissue micro-architectural changes, including those that occur during apoptosis, an early indicator of response to cytotoxicity induced by chemotherapy, thermotherapy, cryotherapy, or radiation therapy. We utilized SFDI to monitor responses of PC3/2G7 prostate tumors and E0771 mammary tumors to treatment with cyclophosphamide or the antiangiogenic agent DC101 for up to 49 days. The SFDI-derived scattering amplitude was highly correlated with cleaved caspase-3, a marker of apoptosis (?p?=?0.75), while the exponent of the scattering wavelength-dependence correlated with the cell proliferation marker PCNA (?p?=?0.69). These optical parameters outperformed tumor volume and several functional parameters (e.g., oxygen saturation and hemoglobin concentration) as an early predictive biomarker of treatment response. Quantitative diffuse optical scattering is thus a promising new early marker of treatment response, which does not require radiation or exogenous contrast agents.

SUBMITTER: Tabassum S 

PROVIDER: S-EPMC7881266 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Optical scattering as an early marker of apoptosis during chemotherapy and antiangiogenic therapy in murine models of prostate and breast cancer.

Tabassum Syeda S   Tank Anup A   Wang Fay F   Karrobi Kavon K   Vergato Cameron C   Bigio Irving J IJ   Waxman David J DJ   Roblyer Darren D  

Neoplasia (New York, N.Y.) 20210209 3


Monitoring of the in vivo tumor state to track therapeutic response in real time may help to evaluate new drug candidates, maximize treatment efficacy, and reduce the burden of overtreatment. Current preclinical tumor imaging methods have largely focused on anatomic imaging (e.g., MRI, ultrasound), functional imaging (e.g., FDG-PET), and molecular imaging with exogenous contrast agents (e.g., fluorescence optical tomography). Here we utalize spatial frequency domain imaging (SFDI), a noninvasive  ...[more]

Similar Datasets

| S-EPMC2667891 | biostudies-other
| S-EPMC6215503 | biostudies-literature
| S-EPMC9774055 | biostudies-literature
| S-EPMC3920889 | biostudies-other
| S-EPMC7401921 | biostudies-literature
| S-EPMC10613237 | biostudies-literature
| S-EPMC5741730 | biostudies-literature
| S-EPMC5400554 | biostudies-literature
| S-EPMC2887284 | biostudies-literature
| S-EPMC5075780 | biostudies-literature